Has the Canadian Diversified Banks Industry valuation changed over the past few years?

Investors are relatively neutral on the industry at the moment, indicating that they anticipate long term growth rates to remain steady. The industry is trading close to its 3-year average PE ratio of 11.3x.

How does Canadian Diversified Banks compare with similar industries?

There is insufficient data on the sub-industries of this industry.

Canadian (TSX) Diversified Banks Industry Analysis

Date	Market Cap	Revenue	Earnings	PE
Tue, 24 May 2022	CA$624.7b	CA$182.9b	CA$58.5b	10.4x
Thu, 21 Apr 2022	CA$670.9b	CA$182.9b	CA$58.5b	11.7x
Sat, 19 Mar 2022	CA$706.3b	CA$182.9b	CA$58.5b	11.7x
Mon, 14 Feb 2022	CA$725.1b	CA$179.6b	CA$56.1b	13x
Wed, 12 Jan 2022	CA$701.4b	CA$179.6b	CA$56.1b	12.5x
Fri, 10 Dec 2021	CA$650.5b	CA$179.6b	CA$56.2b	11.1x
Sun, 07 Nov 2021	CA$648.5b	CA$174.2b	CA$55.0b	11.5x
Tue, 05 Oct 2021	CA$610.3b	CA$174.2b	CA$55.0b	10.9x
Thu, 02 Sep 2021	CA$613.5b	CA$174.2b	CA$55.0b	11.2x
Sat, 31 Jul 2021	CA$604.6b	CA$174.2b	CA$55.0b	11.1x
Tue, 04 May 2021	CA$579.3b	CA$166.1b	CA$49.6b	11.9x
Fri, 05 Feb 2021	CA$497.0b	CA$153.2b	CA$41.6b	11.7x
Mon, 09 Nov 2020	CA$424.1b	CA$150.9b	CA$39.9b	11.1x
Sun, 02 Aug 2020	CA$415.8b	CA$150.8b	CA$37.9b	10.8x
Wed, 06 May 2020	CA$396.4b	CA$152.3b	CA$40.0b	9.4x
Sat, 08 Feb 2020	CA$508.5b	CA$162.8b	CA$46.3b	11.2x
Fri, 01 Nov 2019	CA$516.1b	CA$160.1b	CA$45.0b	11.2x
Mon, 05 Aug 2019	CA$509.4b	CA$158.9b	CA$45.7b	10.5x


CA Market	0.16%
Financials	-0.42%
Banks	-0.42%
Diversified Banks	-0.42%
Regional Banks	0.14%

	Company	Last Price	7D	1Y	Valuation
	NA National Bank of Canada	CA$94.28	2.0% +CA$625.7m	-0.05%	PB1.8x
	RY Royal Bank of Canada	CA$127.25	0.3% +CA$507.1m	3.1%	PB1.9x

May 20

Comera Life Sciences, Inc. completed the acquisition of OTR Acquisition Corp. (NasdaqCM:OTRA) from OTR Acquisition Sponsor LLC, Karpus Management Inc, Polar Asset Management Partners Inc., Hudson Bay Capital Management LP and others in a reverse merger transaction.

Comera Life Sciences, Inc. entered into a letter of intent to acquire OTR Acquisition Corp. (NasdaqCM:OTRA) from OTR Acquisition Sponsor LLC, Karpus Management Inc, Polar Asset Management Partners Inc., Hudson Bay Capital Management LP and others in a reverse merger transaction for approximately $130 million on December 23, 2021. Comera Life Sciences, Inc. entered into an agreement to acquire OTR Acquisition Corp. from OTR Acquisition Sponsor LLC, Karpus Management Inc, Polar Asset Management Partners Inc., Hudson Bay Capital Management LP and others in a reverse merger transaction on January 31, 2022. As per the terms of the transaction, all Comera shares owned by Comera’s existing shareholders will be converted into common stock of Comera Life Sciences Holdings, Inc. At closing, approximately 12.6 million shares of common stock of Comera Life Sciences Holdings, Inc. will be issued to the Comera shareholders at an implied value of $10 per share, before fees and expenses. The transaction also includes an earn-out to existing stockholders of Comera, consisting of approximately 3.15 million additional shares of Comera Life Sciences Holdings, Inc. Post deal completion, Comera will be the surviving company will be directly wholly-owned subsidiary of Comera Life Sciences Holdings, Inc. The combined company will continue to operate under the Comera management team led by Jeff Hackman, Chief Executive Officer; Neal Muni, Chief Operating Officer; Kevin Kavanaugh, Chief Financial Officer; and Robert Mahoney, Chief Scientific Officer. Jim Sherblom will continue to serve as Executive Chairman of the Comera Board of Directors. The transaction has been unanimously approved by both Boards of Directors of Comera and OTR, is subject to approval by stockholders of both OTR and Comera, all parties to the Registration Rights and Lock-Up Agreement and Letter Agreement having delivered duly executed copies of such agreements, OTR having at least $5 million in net tangible assets after giving effect to the exercise of redemption rights by Public Stockholders and other customary closing conditions. The holders of a majority of the Comera voting power have approved the transaction. On February 4, 2022, OTR Acquisition Corp. announced the confidential submission with the U.S. Securities and Exchange Commission of a draft registration statement on Form S-4 relating to the business combination. On April 18, 2022, Comera Life Sciences, Inc. announced that the Securities and Exchange Commission has declared the Registration Statement on Form S-4 filed in connection with the proposed business combination between the two companies, to be effective. As of May 10, 2022, OTR Acquisition's stockholders approved the transaction. The proposed business combination is expected to be completed in the second quarter of 2022. As of May 13, 2022, the transaction is expected to occur on or before May 19, 2022. Comera Life Sciences, Inc. completed the acquisition of OTR Acquisition Corp. (NasdaqCM:OTRA) from OTR Acquisition Sponsor LLC, Karpus Management Inc, Polar Asset Management Partners Inc., Hudson Bay Capital Management LP and others in a reverse merger transaction on May 19, 2022.

Canadian (TSX) Diversified Banks Industry Analysis

Industry Valuation and Performance

Industry Comparison

Top Stock Gainers and Losers

Latest News

RY

President exercised options and sold CA$279k worth of stock

BMO

Comera Life Sciences, Inc. completed the acquisition of OTR Acquisition Corp. (NasdaqCM:OTRA) from OTR Acquisition Sponsor LLC, Karpus Management Inc, Polar Asset Management Partners Inc., Hudson Bay Capital Management LP and others in a reverse merger transaction.

CM

Here's Why I Think Canadian Imperial Bank of Commerce (TSE:CM) Might Deserve Your Attention Today

LB

Laurentian Bank of Canada Announces Resignation of Mr. David Morris from Its Board of Directors

BNS

The Bank of Nova Scotia to Report Q2, 2022 Results on May 25, 2022

NA

National Bank of Canada Appoints Lynn Loewen, to Board

TD

The Toronto-Dominion Bank to Report Q2, 2022 Results on May 26, 2022